中华泌尿外科杂志
中華泌尿外科雜誌
중화비뇨외과잡지
CHINESE JOURNAL OF UROLOGY
2014年
6期
406-409
,共4页
李汉忠%孙颖浩%魏强%殷长军%王玉杰%毕建斌%王春喜%夏术阶%李黎明
李漢忠%孫穎浩%魏彊%慇長軍%王玉傑%畢建斌%王春喜%夏術階%李黎明
리한충%손영호%위강%은장군%왕옥걸%필건빈%왕춘희%하술계%리려명
癌,肾细胞%多中心%病理学,临床%诊断%治疗
癌,腎細胞%多中心%病理學,臨床%診斷%治療
암,신세포%다중심%병이학,림상%진단%치료
Carcinoma,renal cell%Multi-center%Pathology,clinical%Diagnosis%Treatment
目的 统计全国18家医院泌尿外科2008-2012年肾癌患者的诊治资料,分析肾癌发病情况及诊治观念的变化. 方法 统计2008年1月至2012年12月全国18家医院泌尿外科收治肾癌患者的临床资料,对患者的年龄、性别、地域分布、手术方式、术后病理类型、住院日及治疗费用等资料进行分析. 结果 18家医院5年共收治9 725例肾癌患者,其中6 853例具备较完整的临床资料.男4 529例,女2 324例,男女比例为1.95∶1.00.发病年龄1~99岁,平均(56.0±13.3)岁,中位年龄56.0岁.华东及华北地区诊治病例数分别为3 422例及2 153例,多于其他地区.病理类型以透明细胞癌为主,为3 517例(51.32%).6 853例患者中行腹腔镜手术者2495例(36.41%),开放性手术3 891例(56.78%),其他治疗467例(6.81%).手术病例中保留肾单位手术1 935例(30.30%),根治性手术4451例(69.70%).患者总住院时间(16.8±7.8)d,治疗费用为(22 059±9 722)元. 结论 我国肾癌病理类型仍以透明细胞癌为主,手术仍然是主要的治疗手段,腹腔镜手术及保留肾单位手术所占权重在逐渐增加.
目的 統計全國18傢醫院泌尿外科2008-2012年腎癌患者的診治資料,分析腎癌髮病情況及診治觀唸的變化. 方法 統計2008年1月至2012年12月全國18傢醫院泌尿外科收治腎癌患者的臨床資料,對患者的年齡、性彆、地域分佈、手術方式、術後病理類型、住院日及治療費用等資料進行分析. 結果 18傢醫院5年共收治9 725例腎癌患者,其中6 853例具備較完整的臨床資料.男4 529例,女2 324例,男女比例為1.95∶1.00.髮病年齡1~99歲,平均(56.0±13.3)歲,中位年齡56.0歲.華東及華北地區診治病例數分彆為3 422例及2 153例,多于其他地區.病理類型以透明細胞癌為主,為3 517例(51.32%).6 853例患者中行腹腔鏡手術者2495例(36.41%),開放性手術3 891例(56.78%),其他治療467例(6.81%).手術病例中保留腎單位手術1 935例(30.30%),根治性手術4451例(69.70%).患者總住院時間(16.8±7.8)d,治療費用為(22 059±9 722)元. 結論 我國腎癌病理類型仍以透明細胞癌為主,手術仍然是主要的治療手段,腹腔鏡手術及保留腎單位手術所佔權重在逐漸增加.
목적 통계전국18가의원비뇨외과2008-2012년신암환자적진치자료,분석신암발병정황급진치관념적변화. 방법 통계2008년1월지2012년12월전국18가의원비뇨외과수치신암환자적림상자료,대환자적년령、성별、지역분포、수술방식、술후병리류형、주원일급치료비용등자료진행분석. 결과 18가의원5년공수치9 725례신암환자,기중6 853례구비교완정적림상자료.남4 529례,녀2 324례,남녀비례위1.95∶1.00.발병년령1~99세,평균(56.0±13.3)세,중위년령56.0세.화동급화북지구진치병례수분별위3 422례급2 153례,다우기타지구.병리류형이투명세포암위주,위3 517례(51.32%).6 853례환자중행복강경수술자2495례(36.41%),개방성수술3 891례(56.78%),기타치료467례(6.81%).수술병례중보류신단위수술1 935례(30.30%),근치성수술4451례(69.70%).환자총주원시간(16.8±7.8)d,치료비용위(22 059±9 722)원. 결론 아국신암병리류형잉이투명세포암위주,수술잉연시주요적치료수단,복강경수술급보류신단위수술소점권중재축점증가.
Objective To analyze the demographic and clinical data of patients with renal cell carcinoma (RCC) in 18 hospitals throughout China between 2008 and 2012,and to assess the change of concept in RCC management.Methods Demographic and clinical data of RCC patients managed in urology department of 18 hospitals in China was collected and analyzed,including age,gender,type of surgical procedure,surgical pathology,length of hospital-stay,cost of treatment,and geographical distribution.Results A total of 9 725 RCC cases were managed throughout the 5 years in 18 hospitals,among which 6 853 cases had full records,including 4 529 males and 2 324 females,with a male to female ratio of 1.95 ∶ 1.00.Age of presentation ranged from 1 to 99 years,with an average of 56.0 years.The number of the patients in East China and North China were 3 422 and 2 153.Clear cell RCC was the predominant type of pathology,with a total of 3 517 cases (51.32%).Among all the 6 853 patients,there were 2495 cases of laparoscopic surgery (36.41%),3 891 cases of open surgery (56.78%),and 467 others (6.81%).1 935 patients (30.30%) received nephron-sparing surgery,while 4 451 patients (69.70%) had radical nephrectomy.The total length of hospital-stay was (16.8 ± 7.8) d,with the cost of (22 059 ± 9 722) RMB.Conclusions Clear cell RCC is the predominant pathological subtype of RCC.Surgery as always has been the main choice of treatment,with the proportion of laparoscopic surgery and nephron-sparing surgery gradually increasing.